ALPIONER Therapeutics

ALPIONER Therapeutics

Recherche en biotechnologie

Building a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance

À propos

Alpioner Therapeutics is a biotech company developing a whole-cell vaccine platform consisting of genetically optimized strains of human pathogens undergoing an attenuation process which delivers a Killed but Metabolically Active (KBMA) vaccine substance. This platform has already generated a first candidate targeting a human multi-resistant pathogen, Pseudomonas aeruginosa. It carries on the potential for further applications against other resistant pathogens. Alpioner Therapeutics mission is to build a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance (AMR).

Secteur
Recherche en biotechnologie
Taille de l’entreprise
2-10 employés
Siège social
Grenoble
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2023

Lieux

Employés chez ALPIONER Therapeutics

Nouvelles

Pages similaires